Clinical Trial Update: FT576 in Subjects With Multiple Myeloma [Phase 1]

View source ↗

Summary

This document is a status update for a Phase 1 clinical trial of FT576 in multiple myeloma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• FT576

Snippet

Sponsor: Fate Therapeutics | Conditions: Multiple Myeloma, Myeloma | Phase 1 | Status: COMPLETED